| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919180 | Radiotherapy and Oncology | 2013 | 5 Pages |
Abstract
These data show respectable results for patients treated with accelerated hypo-fractionated radiotherapy for NSCLC with outcomes comparable to those reported for similar schedules and represent the largest published series to date for 55/20 regime.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Omar S. Din, Susan V. Harden, Emma Hudson, Nazia Mohammed, Laura S. Pemberton, Jason F. Lester, Debashis Biswas, Lavinia Magee, Aisha Tufail, Ross Carruthers, Ghazia Sheikh, David Gilligan, Matthew Q.F. Hatton,